YD Bio Limited Ordinary Shares logo YDES - YD Bio Limited Ordinary Shares

Price: -- --
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020
Revenue
Revenue 0.6 0.5 0.4 0 0 0
Cost of Revenue 0.6 0.4 0.2 0 0 0
Gross Profit (0.0) 0.2 0.2 0 0 0
Operating Expenses
R&D Expenses 1.6 0.5 0 0 0 0
SG&A Expenses 3.6 1.1 0.2 2.3 1.7 0.3
Other Expenses 0 (0.0) 0.0 0 0 0
Operating Expenses 5.2 1.6 0.2 2.3 1.7 0.3
Operating Income
Operating Income (5.3) (1.5) (0.0) (2.3) (1.7) (0.3)
Interest Expense 0 0.0 0.0 0 0 0
Interest Income 0.1 0.0 0.0 0.0 0.0 0.0
Profitability
EBITDA (8.1) (1.3) 0.0 3.8 8.7 (2.5)
EBIT (8.3) (1.4) 0.0 3.8 8.7 (2.5)
Income Before Tax (8.3) (1.4) 0.0 3.8 8.7 (2.5)
Income Tax Expense (0.0) 0.0 0.0 0.0 0 0
Net Income (8.3) (1.4) 0.0 3.8 8.7 (2.5)
Per Share Data
EPS (Basic) -0.12 -0.56 0.00 0.41 0.59 -0.17
EPS (Diluted) -0.12 -0.56 0.00 0.41 0.59 -0.17
Shares Outstanding 66.7 4.1 70.1 9.3 14.6 14.6
Metric 2025 2024 2023 2022 2021 2020
Current Assets
Cash & Cash Equivalents 6.0 3.1 0.1 0.0 0.0 0.7
Short-Term Investments 0 0 0 0 0 0
Net Receivables 0.7 0.3 0.1 0.0 0 0
Inventory 1.9 0.0 0.1 0 0 0
Other Current Assets 0.0 0 0 0 0 0
Total Current Assets 9.7 3.5 0.3 0.2 0.1 0.8
Non-Current Assets
Property, Plant & Equipment 0.1 0.1 0.0 0 0 0
Goodwill 0 0 0 0 0 0
Intangible Assets 2.6 2.7 0 0 0 0
Long-Term Investments 0 10.5 0.0 17.7 117.9 116.7
Other Non-Current Assets 1.4 (9.9) 0 0 0 0.0
Total Non-Current Assets 4.1 3.4 0.0 17.7 117.9 116.8
Total Assets 13.8 6.9 0.3 17.9 118.1 117.6
Current Liabilities
Account Payables 0.4 0.0 0.0 0 0 0
Short-Term Debt 0 0.0 0.0 0 0 0
Deferred Revenue 0.0 0 0 0 0 0
Other Current Liabilities 0.4 (0.0) 0.0 5.5 2.0 0.3
Total Current Liabilities 1.6 0.3 0.3 5.6 2.0 0.3
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0
Deferred Tax Liabilities 0 0.0 0 0 0 0
Other Non-Current Liabilities 15.0 0.0 2.2 1.2 7.1 17.5
Total Non-Current Liabilities 15.0 0.0 2.2 1.2 7.1 17.5
Total Liabilities 16.6 0.3 0.3 6.7 9.1 17.8
Stockholders' Equity
Common Stock 0.0 0.1 0.1 17.7 115.0 115.0
Retained Earnings (10.2) (1.9) (0.5) (6.5) (6.5) (15.2)
Accumulated Other Comprehensive Income 0.2 0.0 0.0 0 0 0
Total Stockholders' Equity (2.9) 6.6 0.0 11.2 109.0 99.8
Total Liabilities & Equity 13.8 6.9 0.3 17.9 118.1 117.6
Debt Metrics
Total Debt 0.0 0.0 0.0 0 0 0
Net Debt (6.0) (3.1) (0.0) (0.0) (0.0) (0.7)
Metric 2025 2024 2023 2022 2021 2020
Operating Activities
Net Income (8.3) (1.4) 0.0 3.8 8.7 (2.5)
Depreciation & Amortization 0.2 0.1 0.0 0 0 0
Stock-Based Compensation 0 0 0 0 0 0
Change in Working Capital (1.7) (0.6) (0.1) (0.7) 0.6 0.1
Other Non-Cash Items 3.2 0.0 0.1 (6.1) (10.0) 2.2
Operating Cash Flow (6.6) (1.8) (0.1) (3.0) (0.7) (0.3)
Investing Activities
Capital Expenditure (1.4) (2.9) (0.0) 0 (0.0) 0.0
Acquisitions 0 0 0 0 0 0
Purchases of Investments 0 0 (0.5) (1.4) (1.1) (116.7)
Sales/Maturities of Investments 0 0.0 0 0 0 0
Other Investing Activities 0 (2.8) 0.5 101.8 0 0
Investing Cash Flow (1.4) (2.9) (0.0) 100.4 (1.1) (116.7)
Financing Activities
Net Debt Issuance 0 (0.0) (0.0) 4.2 1.1 0
Stock Repurchased 0 0 0 (101.5) 0 0
Dividends Paid 0 0 0 0 0 0
Other Financing Activities 0.2 (0.1) 0.1 0 0 0
Financing Cash Flow 10.9 7.7 0.1 (97.3) 1.1 117.7
Cash Position
Net Change in Cash 2.9 3.0 0.1 0.0 (0.7) 0.7
Cash at Beginning 3.1 0.1 0.0 0.0 0.7 0
Cash at End 6.0 3.1 0.1 0.0 0.0 0.7
Free Cash Flow (8.0) (4.7) (0.1) (3.0) (0.7) (0.3)
Key Metrics 2025 2024 2023 2022 2021 2020
Income Statement
Revenue 0.6 0.5 0.4 0 0 0
Gross Profit (0.0) 0.2 0.2 0 0 0
Operating Income (5.3) (1.5) (0.0) (2.3) (1.7) (0.3)
Net Income (8.3) (1.4) 0.0 3.8 8.7 (2.5)
EPS (Diluted) -0.12 -0.56 0.00 0.41 0.59 -0.17
Balance Sheet
Cash & Equivalents 6.0 3.1 0.1 0.0 0.0 0.7
Total Assets 13.8 6.9 0.3 17.9 118.1 117.6
Total Debt 0.0 0.0 0.0 0 0 0
Stockholders' Equity (2.9) 6.6 0.0 11.2 109.0 99.8
Cash Flow
Operating Cash Flow (6.6) (1.8) (0.1) (3.0) (0.7) (0.3)
Capital Expenditure (1.4) (2.9) (0.0) 0 (0.0) 0.0
Free Cash Flow (8.0) (4.7) (0.1) (3.0) (0.7) (0.3)